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Abstract
Background: The superiority of the diagnostic power of different definitions of metabolic syndrome (MetS) in
detecting objective and subjective cardiovascular outcomes is under debate. We sought to compare diagnostic
values of different insulin resistance (IR)-based definitions of MetS in detecting poor health-related quality of life
(HRQoL) in a large sample of Tehranian adults.
Methods: This cross-sectional study conducted within the framework of the Tehran Lipid and Glucose Study on a total
sample of 742 individuals, aged≥ 20 years. Metabolic syndrome was defined according to the World Health Organization
(WHO), the European Group for the study of Insulin Resistance (EGIR), and the American Association of Clinical
Endocrinology (AACE). Health-related quality of life was assessed using the Short Form Health Survey (SF-36). Logistic
regression analysis and Receiver Operating Characteristic (ROC) curve were used to investigate the impact of the three
IR-based definitions of MetS on HRQoL and compare their discriminative powers in predicting poor HRQoL.
Results: Compared with other definitions, the WHO definition identified more participants with MetS (41.8 %).
Although the AACE definition had higher adjusted odds ratios for reporting poor physical HRQoL (OR: 1.95; CI:
0.84–4.53 and OR: 1.01; CI: 0.55–1.85 in men and women respectively) and mental HRQoL (OR: 0.97; CI: 0.41–2.28
and OR: 1.00; CI: 0.56–1.79 in men and women respectively), none of the three studied definitions were significantly
associated with poor physical or mental HRQoL in either gender; nor did ROC curves show any significant difference in
the discriminative powers of IR-based definitions in detecting poor HRQoL in either gender.
Conclusions: None of the three studied IR-based definitions of MetS could significantly detect poor HRQoL in the
physical or mental domains, indicating no significant superior diagnostic value for any of these definitions.
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Background
Metabolic syndrome (MetS), an escalating health issue
worldwide, is a constellation of metabolic abnormalities,
which are the major risk factors for developing cardio-
vascular disease (CVD) and diabetes type 2 [1]. Fast
increasing evidence shows the negative effect of MetS
on health-related quality of life (HRQoL) as a subjective
patient-centered health measurement that concentrates
on the individual's own perception of their health status
and life satisfaction [2]. Recent data reveals that the
prevalence of the syndrome is fast increasing in different
populations [3] and is reported to be approximately
34.7 % in Iranian adults [4].
Despite much research have been conducted in recent
years, there is uncertainty regarding the concept of MetS
and critical investigations have questioned whether the
syndrome is a mere aggregation of metabolic abnormal-
ities or a syndrome representing a clinical entity [5].
This doubt has resulted in the introduction of several
definitions that include risk factor components which
are not entirely similar and more importantly, the cut-
offs used for defining them differ. Insulin resistance (IR);
the most accepted pathophysiology of MetS, is likely a
significant link between the components of this syn-
drome [1]. On the other hand, obesity, which is included
in most definitions of MetS, is identified as the most im-
portant correlate of the increasing prevalence of MetS
[1]; in addition it has been proposed that IR is
significantly related to central obesity [6]. Among the
proposed definitions, the World Health Organization
(WHO) [7], the European Group for the study of Insulin
Resistance (EGIR) [8], and the American Association of
Clinical Endocrinology (AACE) [9] emphasize IR as the
major component of MetS; however, the National Chol-
esterol Education Program Adult Treatment Panel III
(NCEP-ATP III), the American Heart Association/Na-
tional Heart, Lung, and Blood Institute (AHA/NHLBI),
the International Diabetes Federation (IDF) and the joint
interim statement (JIS), emphasize waist circumference
(WC) [10].
Considering the above mentioned ambiguity, several
efforts have been made to explore the superior diagnos-
tic powers of the WC- and IR-based definitions of MetS
in detecting objective and subjective cardiovascular out-
comes, i.e. CVD and HRQoL. Regarding objective CVD
complications, evidence shows that except for the EGIR
definition, the NCEP/AHA, AACE, IDF and modified
WHO definitions are all associated with cardiovascular
events among an elderly American population [11]. The
results of a recent study of the Tehran lipid and glucose
study (TLGS) population revealed no differences among
diagnostic values of WC-based definitions of MetS in
detecting coronary heart disease (CHD) and CVD [12].
Furthermore, in a Dutch population, compared to the
WC-based definitions of MetS, IR-based definitions had
lower hazards ratios in detecting cardiovascular events
[13]. In the field of subjective outcomes, the association
between WC-based definitions of MetS and HRQoL,
especially in the physical domain and mainly in women
has been reported [14]. We recently showed that
these definitions failed to show any superiority in the
discriminative powers in detecting poor HRQoL in
Tehranian adults without diabetes [15]. Although the
association between IR and HRQoL has been docu-
mented [16] there is no study reporting the associ-
ation between IR-based definitions of MetS and
HRQoL. As one of the first efforts, this study aimed
to investigate diagnostic values of three IR-based defi-
nitions of MetS including WHO, EGIR and AACE to




The current study was conducted within the framework
of the TLGS, a large scale ongoing community based
prospective study being performed on a representative
sample of residents of district-13 of Tehran, the capital
of Iran. Details of the rationale and design of the TLGS
have been published elsewhere [17]. The TLGS has two
major components: 1) a cross-sectional prevalence study
of non-communicable diseases and their associated risk
factors implemented from 1999 to 2001 and 2) a pro-
spective follow-up study in which non-communicable
diseases risk factors are measured approximately every
3 years.
In the current study, a total of 742 individuals,
aged ≥ 20 years, with insulin measurements, participating
in the TLGS between September 2005 and September
2007 (the second follow-up), was recruited. Information
data of these 742 participants was analyzed using the
WHO definition. For EGIR and AACE definitions, after
excluding 135 persons with diabetes and 17 persons with
missing data, the information of 590 persons met the in-
clusion criteria and was analyzed. The study was approved
by the ethics committee of the Research Institute for
Endocrine Sciences, Shahid Beheshti University of
Medical Sciences and written informed consent was
obtained from all participants.
HRQoL measures
To assess HRQoL, we used the Iranian version of Short
Form Health survey (SF-36), which has been validated in
Iran [18]; this widely used questionnaire contains 36
questions summarized into eight subscales; four physical
health related subscales including physical functioning,
role limitations due to physical health problems, bodily
pain, general health and also four mental health-related
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subscales including vitality, social functioning, role limi-
tations due to emotional problems, and mental health.
The physical subscales are summarized and termed as
the physical component summary (PCS) and similarly
the four mental subscales are termed as the mental
component summary (MCS) [19]. The score attrib-
uted to each subscale ranges from 0 to 100 as the
worst and the best conditions of health respectively.
Calculating of the PCS and the MCS scores was done
using the Quality Metric Health Outcomes Scoring
Software 2 [20].
Definitions
Metabolic syndrome was defined according to the WHO
[7], EGIR [8] and AACE [9] criteria (Table 1). Based on
the criteria of the American Diabetes Association (ADA),
diabetes was defined as fasting plasma glucose ≥ 7 mmol/
L, 2-h post 75 g glucose load ≥ 11.1 mmol/L or receiving
antidiabetic medications [21]. Insulin resistance was de-
fined as the upper quartile of insulin level of baseline
population from the second follow-up of TLGS. After
excluding patients with diabetes, those who had received
educational intervention, and participants of the current
study, the cut point for IR was calculated. The median
[range] insulin concentration was 7.45 mU/ml [0.2–
51.84] with an upper quartile range of ≥10.63. Meno-
pause was defined as the time of cessation of menstrual
periods for 12 consecutive months, not due to surgery
or any other biological or physiological causes [22]. Im-
paired glucose regulation was defined according to the
criteria of the ADA as fasting blood glucose 5.6 mmol/L
to 6.9 mmol/L or 2-h post 75 g glucose load 7.8 mmol/
L to 11.1 mmol/L [21]. Smoking status was considered
in two groups: 1) Non- and ex-smokers and 2) Current
smokers. Additional information regarding age, physical
activity [23] and current use of oral hypoglycemic agents,
lipid-lowering and anti-hypertensive medication were
obtained using the TLGS data.
Other measures
Waist circumference was measured at the umbilical
level, over light clothing, using an unstretched tape
meter, without any pressure to body surface and mea-
surements were recorded to the nearest 0.1 cm. Blood
pressure was measured twice, after participants were
seated for 15 min, using a standard mercury sphygmo-
manometer; there was at least 30s interval between these
two separate measurements and the mean of two mea-
surements was recorded as the participants blood pres-
sure. Twelve-hour fasting blood samples were collected
in tubes containing 0.1 % EDTA and were centrifuged at
4 °C and 500 × g for 10 min, to separate the plasma.
Blood glucose was measured on the day of blood col-
lection by an enzymatic colorimetric method using glu-
cose oxidase. Fasting serum insulin was determined by
the electrochemiluminescence immunoassay (ECLIA)
method, using Roche Diagnostic kits and the Roche/
HitachiCobas e-411 analyzer (GmbH, Mannheim,
Germany). Serum total cholesterol and triglyceride
concentrations were measured with commercially
available enzymatic reagents (Pars Azmoon, Tehran,
Iran) adapted to a selectraautoanalyzer. High density
lipoprotein-cholesterol (HDL-C) was measured after
precipitation of the apolipoprotein B-containing
Table 1 Different definitions and their cut-offs used to define the metabolic syndrome
World Health Organization (WHO) European Group for the study of Insulin
Resistance (EGIR)
American Association of Clinical
Endocrinology (AACE)
Absolutely required IGTa or IFGb or IRc or diabetes Plasma insulin > 75 percentile of persons
without diabetes in the population
under study.
High risk of being insulin resistant d
(excluding diabetes)
Criteria plus two or more of the below
abnormalities
plus two or more of the four below
abnormalities
Plus two or more of the four
below abnormalities
Adiposity index WHR > 0.90 in men and >0.85 in
women and/or BMI > 30 kg/m2
WC≥ 94 cm in men and ≥80 cm
in women
none
Triglycerides ≥1.7 mmol/L and/or >2 mmol/L and/or >1.7 mmol/L
HDL <0.9 mmol/L in men and <1.0 mmol/L
in women
<1.0 mmol/L or treated for dyslipidemia <1.0 mmol/L in men and <1.3 mmol/L
in women.
Blood pressure ≥140/90 mmHg or treated for
hypertension
≥140/90 mmHg or treated for
hypertension
≥130/85 mmHg or treated for hypertension
Hyperglycemia none Fasting plasma glocuse≥ 6.1 mmol/L
(but without diabetes)
Fasting plasma glucose 6.1–6.9 mmol/L
or IGT
BMI, body mass index; WC, waist circumference; IGT, impaired glucose tolerance; IFG, impaired fasting glucose; HDL, high density lipoprotein; WHR, waist to hip
ratio a120 min post glucose challenge (75 mg):7.8–11.1 mm/L bFasting plasma glucose 5.6–7.00 mm/L cdefined as plasma insulin > 75 percentile of persons
without diabetes in the population under study dFor the AACE definition, high risk of being insulin resistant is indicated by the presence of at least one of the
followings: diagnosis of hypertension or cardiovascular disease; family history of type 2 diabetes or history of gestational diabetes or glucose intolerance; BMI >
25 kg/m2 or WC > 94 cm (men), >80 cm (women); age >40 years
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lipoproteins with phosphotungistic acid. Low density
lipoprotein-cholesterol was calculated from serum total
cholesterol, triglycerides (TG), and HDL-C, except
when TG concentration was > 4.5 mmol/L [17].
Statistical analysis
By use of graphical methods, continuous variables were
checked for normality and are expressed as mean ± SD.
Distribution of variables with normal and non - nor-
mal distributions between two groups and also cat-
egorical variables were compared using sample t-test,
Mann–Whitney test and χ2 test respectively; categorical
variables are reported as percentages.
Poor HRQoL was defined as the first tertile of PCS or
MCS and to compute the odds ratios (ORs), logistic re-
gression analysis was used. Sex specific ORs with 95 %
confidence intervals were computed for men and
women separately; model 2 was adjusted for age (years)
and model 3 was adjusted for age, smoking (only in
men-Ref: never smoked or ex-smoker), education (Ref:
above high school), menopause (only in women-Ref:
productive age) and marital status (Ref: married). In
women, smoking was not adjusted in model 3 because
Table 2 General characteristics of study participants
All (n = 742) Men (n = 246) Women (n = 496) P-value
Age (y) 49.78 (13.25) 51.25 (14.13) 49.06 (12.75) 0.04
Education (%) <0.001
Primary 358 (49.1) 80 (33.2) 278 (57.0)
Secondary 265 (36.4) 104 (43.2) 161 (33.0)
Higher 106 (14.5) 57 (23.7) 49 (10.0)
Marital status (%) <0.001
Married 632 (85.2) 226 (91.9) 406 (81.9)
Single/Widowed/Divorced 110 (14.8) 20 (8.1) 90 (18.1)
Smoking (%) <0.001
Current 46 (6.3) 41 (17.0) 5 (1.0)
Ex/Never 680 (93.7) 200 (83.0) 480 (99.0)
MET-h/wk 22.1 (7.7–58.1) 23.3 (7.9–63.1) 20.3 (7.6–57.5) 0.80
WHR 0.9 (0.1) 1.0 (0.1) 0.9 (0.1) <0.001
WC (cm) 95.3 (11.6) 98.1 (10.2) 93.9 (12.0) <0.001
BMI (kg/m2) 29.1 (4.7) 27.8 (4.4) 29.7 (4.8) <0.001
TG (mmol/L) 1.8 (1.3–2.5) 1.9 (1.3–2.7) 1.8 (1.2–2.4) 0.10
Total cholesterol (mmol/L) 5.2 (1.0) 5.1 (0.9) 5.3 (1.0) <0.001
HDL-C (mmol/L) 1.1 (0.3) 1.0 (0.2) 1.1 (0.3) <0.001
LDL-C (mmol/L) 3.3 (0.8) 3.2 (0.8) 3.3 (0.9) 0.11
FBS (mmol/L) 5.7 (1.9) 5.8 (1.8) 5.7 (2.0) 0.32
BS2hr (mmol/L) 6.5 (2.7) 6.2 (2.5) 6.6 (2.8) 0.07
SBP (mmHg) 120.2 (19.0) 124.0 (16.7) 118.3 (19.8) <0.001
DBP (mmHg) 75.1 (10.1) 77.0 (10.0) 74.2 (10.1) <0.001
Menopause (%) - - 165 (34.3) -
Pre-diabetes (%) 150 (20.7) 51 (21.2) 99 (20.5) 0.80
Metabolic Syndrome (%)
WHO 302 (41.8) 107 (44.2) 195 (40.6) 0.36
aEGIR 149 (25.6) 49 (25.8) 100 (25.5) 0.94
aAACE 179 (30.7) 62 (33.2) 117 (29.5) 0.37
Data represented as mean (SD) for continuous variables with normal distribution and median (25 percentile-75 percentile) for continuous variables with non-normal
distribution or n (%) for categorically distributed variables
P-values according to independent sample t-test, χ2-test and Mann–Whitney test between genders
BMI, body mass index; WC, waist circumference; IGT, impaired glucose tolerance; IFG, impaired fasting glucose; HDL, high density lipoprotein; WHR, waist to hip
ratio; WHO, World Health Organization; EGIR, European Group for the study of Insulin Resistance; AACE, American Association of Clinical Endocrinology
a The number of study participants for EGIR and AACE definitions is 590
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of the low number of smokers in this group. Statistical
analysis was performed using SPSS software version 16
(SPSS Inc., Chicago, IL, USA), with significance set at
p < 0.05. To evaluate the power of each of the three
definitions of the MetS in predicting poor physical
and mental HRQoL among the study population, the
area under the curve (AUC) was computed for the
fully adjusted model (model 3). Differences between
areas under the receiver operating characteristic
(ROC) curves for the different MetS definitions were
tested using STATA software version 10 (STATA Inc.,
College Station, TX, USA).
Results
General metabolic and clinical characteristics of study
participants are listed in Table 2; compared to
women, men had higher mean levels of WC, SBP,
DBP (P < 0.001), but lower HDL-C (P < 0.001); compared
to women, rates of higher education and married subjects
were significantly higher in men (P <0.001). According to
different MetS definitions, more participants (41.8 %) met
the WHO definition, followed by AACE (30.7 %) and
EGIR (25.6 %) criteria.
Both in the physical and mental domains, more men
had higher scores in all subscales of SF-36 indicating
better HRQoL; however the score of role emotional sub-
scale was higher in women by all three definitions.
Among the subscales, physical and social functioning
got the highest scores in both men and women respect-
ively according to all three definitions (Table 3).
Table 4 shows the risk of being in the lowest tertile of
PCS and MSC according to MetS status by each three
definitions. There was no remarkable difference between
the rates of poor HRQoL in any of the definitions or
either gender. Unadjusted odds ratios (95 % CI) for poor
physical health for the WHO, EGIR and AACE defini-
tions were 1.89 (1.00–3.57), 2.04 (0.83–5.03), 1.75 (0.82–
3.71) for men respectively, while, in women, they were
1.51 (0.97–2.37), 1.21 (0.67–2.19), 1.56 (0.92–2.64) re-
spectively, significant only in men based on the WHO
definition (Table 4).
Compared with women, after adjustment for con-
founding variables, in physical HRQoL all definitions
showed higher odds ratios in men as follows: WHO 1.72
(95 % CI; 0.88–3.35) vs. 0.96 (95 % CI; 0.57–1.60), EGIR
1.80 (95 % CI; 0.69–4.96) vs. 0.93 (95 % CI; 0.48–1.81),
AACE 1.95 (95 % CI; 0.84–4.53) vs. 1.01 (95 % CI; 0.55–
1.85); however, in mental HRQoL women had higher
odds ratios than men. Although only men with WHO-
defined MetS had significant odds ratio for reporting
poor physical HRQoL, after adjustment for confounding
factors the AACE definition had higher odds ratio for
reporting poor physical HRQoL in both genders. In this
definition, in physical HRQoL, the odds ratio increased
after controlling confounding factors (Table 4).
After adjustment for confounding variables, ROC ana-
lysis showed no significant superiority in the discrimin-
atory powers of the three different MetS definitions in
detecting poor HRQoL in physical or mental domains in
either gender. However, especially in physical health,
women showed higher AUCs for all definitions, in com-
parison to men (Table 4).
Discussion
In the current study, after adjusting confounding vari-
ables, none of the three IR-based definitions of MetS
could significantly detect poor HRQoL in the physical or
mental domains. Moreover ROC analysis showed no sig-
nificant superior diagnostic value for any of the three
definitions; however the WHO definition identified more
patients with MetS (41.8 %) than the other IR-based
Table 3 Scores of the 36-item Short Form health survey (SF-36),




Physical functioning 79.4 (45.3) 79.2 (47.3) 76.5 (45.8)**
Role physical 68.3 (83.1) 69.2 (89.2) 62.3 (87.5)
Bodily pain 73.2 (45.9) 73.2 (49.5) 69.6 (48.7)
General health 66.4 (49.1) 65.0 (52.2) 64.4 (51.0)
Vitality 68.9 (47.1) 69.7 (51.4) 68.9 (50.3)
Social functioning 77.5 (59.9) 72.7 (66.4) 75.1 (65.2)
Role emotional 58.2 (102.4) 48.5 (107.1) 53.5 (104.9)
Mental health 73.1 (46.7) 71.3 (52.1) 74.7 (51.1)
PCS 71.8 (41.9) 71.6 (43.5) 68.2 (42.4)
MCS 69.4 (50.3) 65.6 (53.7) 68.1 (52.6)
Women
Physical functioning 76.7 (46.4) 76.4 (53.0) 72.9 (49.5)*
Role physical 63.2 (75.8) 69.2 (86.8) 68.1 (81.3)
Bodily pain 70.3 (43.2) 69.6 (48.5) 70.1 (45.2)
General health 64.5 (39.5) 65.9 (44.5) 64.3 (41.7)
Vitality 59.8 (43.4) 60.7 (50.3) 58.7 (46.8)
Social functioning 74.4 (49.0) 76.2 (56.1) 72.4 (52.3)
Role emotional 65.9 (81.2) 66.8 (93.4) 67.4 (86.8)
Mental health 66.7 (41.0) 65.8 (47.2) 64.1 (43.6)
PCS 68.7 (38.6) 70.3 (44.1) 68.9 (41.3)
MCS 66.7 (42.1) 67.4 (48.3) 65.6 (45.2)
Data represented as mean (SD)
WHO, World Health Organization; EGIR, European Group for the study of
Insulin Resistance; AACE, American Association of Clinical Endocrinology; PCS,
physical component summary; MCS, mental component summary
* 0.05 ≤ p ≤ 0.07 for poor health-related quality of life which is not significant
in α = 0.05 but is significant in α = 0.10
** P < 0.05 for poor health-related quality of life
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definitions. Only the WHO definition of MetS signifi-
cantly detected poor physical quality of life in men be-
fore adjustment for potential confounders.
Although previous studies have documented the pre-
dictive value of different WC-based definitions of MetS
on the objective and subjective outcomes of CVD and
HRQoL [13, 15], to the best of our knowledge, this is
the first report comparing the diagnostic values of the
IR-based definitions of this syndrome in detecting poor
HRQoL. Findings from studies investigating the impact
of MetS on the risk of CVD, as a measurable outcome,
show both similarities and differences. Based on previ-
ous findings, compared to the IR-based definitions, the
WC-based definitions of MetS showed a superior pre-
dictive value of non- fatal CVD among an elderly Dutch
population [13]; Consistent to this, another study
showed that WHO and EGIR definitions were associated
with lower risk of all cause CVD than WC-based defini-
tions in men enrolled in a multiethnic study [24].
Moreover, a study conducted in Turkey, reported that
Table 4 Odds ratio (95 % CI) and area under the curve (AUC) for poor physical and mental HRQoL according to different definitions
of metabolic syndrome
WHO EGIR AACE
Physical component summary (PCS)
Men
Number of individuals with MetS and poor HRQoL(%) 37 (34.6) 16 (32.7) 24 (38.7)
Adjusted Odds ratio (95 % CI)
Model 1 1.89 (1.00–3.57)** 2.04 (0.83–5.03) 1.75 (0.82–3.71)
Model 2 1.83 (0.96–3.49)* 2.05 (0.83–5.07) 1.72 (0.77–3.84)
Model 3 1.72 (0.88–3.35) 1.80 (0.69–4.69) 1.95 (0.84–4.53)
AUC 0.64 (0.56–0.73) 0.66 (0.56–0.75) 0.66 (0.56–0.76)
Women
Number of individuals with MetS and poor HRQoL 70 (35.9) 30 (30) 46 (39.3)
Adjusted Odds ratio (95 % CI)
Model 1 1.51 (0.97–2.37)* 1.21 (0.67–2.19) 1.56 (0.92–2.64)
Model 2 1.08 (0.67–1.75) 1.06 (0.57–1.96) 0.98 (0.55–1.76)
Model 3 0.96 (0.57–1.60) 0.93 (0.48–1.81) 1.01 (0.55–1.85)
AUC 0.73 (0.68–0.79) 0.74 (0.67–0.80) 0.73 (0.67–0.79)
Mental component summary (MCS)
Men
Number of individuals with MetS and poor HRQoL(%) 33 (30.8) 17 (34.7) 18 (29)
Adjusted Odds ratio (95 % CI)
Model 1 0.92 (0.49–1.73) 1.16 (0.52–2.59) 0.74 (0.35–1.58)
Model 2 0.95 (0.50–1.80) 1.17 (0.52–2.62) 0.80 (0.36–1.81)
Model 3 0.75 (0.37–1.49) 0.93 (0.38–2.23) 0.97 (0.41–2.28)
AUC 0.63 (0.54–0.71) 0.65 (0.55–0.75) 0.65 (0.55–0.74)
Women
Number of individuals with MetS and poor HRQoL(%) 71 (36.4) 36 (36) 43 (36.8)
Adjusted Odds ratio (95 % CI)
Model 1 1.14 (0.73–1.77) 1.15 (0.66–1.99) 1.25 (0.74–2.12)
Model 2 1.00 (0.63–1.58) 1.07 (0.61–1.88) 1.01 (0.57–1.77)
Model 3 0.89 (0.55–1.45) 0.97 (0.54–1.74) 1.00 (0.56–1.79)
AUC 0.65 (0.59–0.71) 0.66 (0.59–0.73) 0.65 (0.59–0.72)
WHO, World Health Organization; EGIR, European Group for the study of Insulin Resistance; AACE, American Association of Clinical Endocrinology; HRQoL, Health
related quality of life
Model 1: Unadjusted, Model 2: Adjusted for age, Model 3: Adjusted for age, smoking (only in men) (Ref: Never or ex-smoking), education (Ref: Above high school
education), marital status (Ref: Married) and menopause (Ref: reproductive age)
* 0.05 ≤ p ≤ 0.07 for poor health-related quality of life
** P < 0.05 for poor health-related quality of life
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WC-based definitions of MetS were more useful than IR
- based definitions in showing increased Framingham
risk of cardiovascular disease [25], results consistent
with those of our previous study, showing that most of
the WC-based definitions had a significant association
with poor HRQoL [15]. It seems that central adiposity,
the stem of WC-based definitions, plays the main role in
MetS objective and subjective outcomes [26].
Can et al. showed that, in an adult Turkish population
the AACE definition of MetS identified more individuals
at increased cardio-metabolic risk than the WHO or
EGIR definitions, a result consistent with that of our
study showing the highest odds ratio of having poor
HRQoL in the AACE definitions compared to WHO
and EGIR definitions; however it should be considered
that in the Turkish sample, the AACE definition de-
tected more patients having MetS than the WHO and
EGIR definitions, which is contrary to our findings, in
which the WHO definition detects the highest rate of
individuals with MetS [25].
Although in our previous study, the association between
poor physical HRQoL and different WC-based definitions
of MetS was significant in women but not in men [14], in
the current study it is interesting to note that the odds of
having poor physical HRQoL is lower in women than in
men, a sex specific difference which may be associated to
the use of IR as the main component of MetS definitions
used in this study; in this regard, a study by Schlotz et al.
assessing the relation between IR and HRQoL, showed a
significant association between poor HRQoL and some
subscales of PCS in men but not women after controlling
for confounding variables [16]. Based on the Masharani et
al. findings, this sex specific difference in the association
between IR-based definitions of MetS with HRQoL may
be due to sex differences in the associations between insu-
lin resistance, regional adipose stores, and lipids values
which may result in higher prevalence of obesity and high
WC in men in association with IR [27]; this is while previ-
ous studies revealed that abdominal obesity is the major
component of association between MetS and poor
HRQoL in women [28]. On the other hand, in type 2 dia-
betic patients, which is one of the main manifestations of
IR, women compared to men, showed worse quality of life
and mental well-being [29].
Based on our findings, the IR-based definitions of
MetS were not associated with the mental HRQoL in
any of the three definitions, results consistent with those
of our previous study in which WC-based definitions of
MetS showed no significant association with poor men-
tal HRQoL in adult Tehranians [15]. Moreover previous
studies have shown that IR and its related measures are
associated with poor HRQoL in the domains of physical
health but not in domains of mental health [16]. The as-
sociation between IR and depression has been shown in
some previous studies, including a recent meta-analysis,
in which a small, but significant association was ob-
served between IR and depression [30], an observation
not found in our study.
Based on our knowledge, this is the first report com-
paring the diagnostic impact of different IR based defini-
tions of the metabolic syndrome in a large sample of
adults in the general population. Our study has some
limitations; first, this study was conducted using a cross
- sectional design, so we are unable to draw conclusions
regarding the causal association between MetS and
HRQoL. Second, there may be yet other confounding
factors such as depression and economic status that
affect HRQoL, factors that we did not adjust for. Third,
since the three definitions of MetS tended to be associ-
ated with poor physical HRQoL in men, the lack of sig-
nificant statistical results could be related to low
statistical power. Moreover, microalbuminuria, which is
included in the WHO definition, was omitted from our
study because of lack of data. Finally in the AACE defin-
ition, due to inadequate information, we did not include
acanthosis nigricans, polycystic ovary syndrome, nonal-
coholic fatty liver disease, non-Caucasian ethnicity and
sedentary life style in the criteria needed for an individ-
ual to be considered at high risk of being insulin
resistant.
Conclusions
Although the AACE definition had a higher odds of hav-
ing poor physical HRQoL compared to the WHO and
EGIR definitions of MetS, none the three definitions
could detect poor HRQoL after adjusting potential con-
founders in either physical or mental domains in men
and women. Accordingly, ROC analysis failed to show
any significant superiority in the discriminatory power of
the different definitions over each other.
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